A team led by the Cancer Immunogenomics group at the Josep Carreras Leukaemia Research Institute, the Computational Biology group at the Barcelona Supercomputing Center and the Germans Trias i Pujol ...
An enhanced model that integrates non-AJCC clinical features provides clinicians with a more accurate tool for identifying high-risk patients with MCC.
"What is a tumor?" This is the fundamental question to answer if we want to treat cancer effectively. Our vision of cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback